The present study is aimed at characterizing the carbon dioxide (CO2) procedure in healthy subjects to achieve reliable provocation of anxiety symptoms.
Thirty healthy subjects inhaled in single-blind both compressed air and 7% CO2 mixture. Panic Symptom List (PSLIII-R), Visual Analogue Scale-Anxiety (VAS-A), State Anxiety Inventory (STAI-Y/1), respiratory parameters and skin conductance were measured. ‘Responders’ were classified depending on PSLIII-R scores after CO2. Twelve out of the 21 ‘responders’ performed a second test to assess test-retest repeatability.
In 21 subjects%VAS-A (45.4 32.1) and PSLIII-R (pre-test 2.3 2.1, post-test 17.5 8.2) but not STAI-Y/1, significantly increased during CO2 inhalation. Respiratory Rate, Minute Volume, end-Tidal CO2 and skin conductance rose in ‘responders’. Repeatability was studied with Bland-Altman plots, revealing mean difference between tests close to 0 for both%VAS-A and PSLIII-R. Among physiologic parameters, end-Tidal CO2 and Respiratory Rate showed good repeatability, with a within-subject CV of 9.2% and 6%, respectively.
The challenge produced measurable response in healthy subjects. Good test-retest repeatability was observed in ‘responders’. These data indicate that the test can be suitable for testing putative anti-panic or anxiolytic drugs in clinical studies using a within subject, crossover design.
Abelson J L, Weg J G, Nesse R M, Curtis G C (2001) Persistent respiratory irregularity in patients with panic disorder. Biol Psychiatry49: 588-595
2.
Argyropoulos S V, Bailey J E, Hood S D, Kendrick A H, Rich A S, Laszlo G, Nash J R, Lightman S L, Nutt D J. (2002) Inhalation of 35% CO2 results in activation of the HPA axis in healthy volunteers. Psychoneuroendocrinology27: 715-729
3.
Bailey J E, Argyropoulos S V, Lightman S L, Nutt D J (2003) Does the brain noradrenaline network mediate the effects of the CO2 challenge?J Psychopharmacol. 17: 252-259
4.
Barlow D H, Brown T A, Craske M G (1994) Definitions of panic attack and panic disorder in DSM-IV: implications for research. J Abnormal Psychology103: 553-564
5.
Battaglia M, Perna G (1995) The 35% CO2 challenge in panic disorder: optimization by receiver operating characteristic (ROC) analysis. J Psychiat. Res29: 111-119
6.
Battaglia M, Bertella S, Ogliari A, Bellodi L, Smeraldi E (2001) Modulation by muscarinic antagonists of the response to carbon dioxide challenge in panic disorder. Arch Gen Psychiatry58: 114-119
7.
Battaglia M (2002) Beyond the usual suspects: a cholinergic route for panic attacks. Mol Psychiatry7: 239-246
8.
Bertani A, Caldirola D, Bussi R, Bellodi L, Perna G (2001) The 35% CO2 hyperreactivity and clinical symptomatology in patients with panic disorder after 1 week of treatment with citalopram: an open study. J Clin Psychopharmacol21: 262-267
9.
Bland J M, Altman D G (1986) Statistical methods for assessing agreement between two methods of clinical measurement. The Lancet8: 307-310
10.
Bloomfield P (2000): Fourier analysis of time series: an introduction. J. Wiley & Sons, New York
11.
Bystritsky A, Craske M, Maidenberg E, Vapnik T, Shapiro D (2000) Autonomic reactivity of panic patients during a CO2 inhalation procedure. Depression and Anxiety11: 15-26
12.
Caldirola D, Bellodi L, Caumo A, Migliarese G, Perna G (2004a) Approximate entropy of respiratory patterns in panic disorder. Am J Psychiatry161: 79-87
13.
Caldirola D, Bellodi L, Cammino S, Perna G (2004b) Smoking and respiratory irregularity in panic disorder. Biol Psychiatry56: 393-398
14.
Coryell W (1997) Hypersensitivity to carbon dioxide as a disease-specific trait marker. Biol Psychiatry41: 259-263
15.
Damasio A R (1995) Toward a neurobiology of emotion and feeling: operational concepts and hypothesis. Neuroscientist1: 19-25
16.
Forsyth J P, Eifert G H, Canna M A (2000) Evoking analogue subtypes of panic attacks in a nonclinical population using carbon dioxide-enriched air. Behaviour Research and Therapy38: 559-572
17.
Goetz R R, Klein D F, Papp L A, Martinez J M, Gorman J M (2001) Acute panic inventory symptoms during CO2 inhalation and room-air hyper-ventilation among panic disorder patients and normal control. Depression and Anxiety14: 123-136
18.
Gorman J M, Goetz R R, Dillon D, Liebowitz M R, Fyer A J, Davies S, Klein D F. (1990a) Sodium D-lactate infusion of panic disorder patients. Neuropsychopharmacology3: 181-189
19.
Gorman J M, Papp L A, Martinez J M, Goetz R R, Hollander E, Liebowitz M R, Jordan F. (1990b) High dose carbon dioxide challenge test in anxiety disorder patients. Biol Psychiatry28: 743-757
20.
Gorman J M, Papp L A, Coplan J M, Martinez J M, Lennon S, Goetz R, Ross D, Klein D F. (1994) Anxiogenic effects of CO2 and hyperventilation in patients with panic disorder. Am J Psychiatry151: 547-553
21.
Gorman J M, Browne S T, Papp L A, Martinez J M, Welkowitz L, Coplan J D, Goetz R R, Kent J, Klein D F. (1997) Effect of antipanic treatment on response to carbon dioxide. Biol Psychiatry42: 982-991
22.
Gorman J M, Kent J, Martinez J M, Browne S, Coplan J, Papp L A (2001) Physiological changes during carbon dioxide inhalation in patients with panic disorder, major depression and premenstrual dysphoric disorder: evidence for a central fear mechanism. Arch Gen Psychiatry58: 125-131
23.
Griez E, Lousberg H, van den Hout M A, van der Molen M G (1987) CO2 vulnerability in panic disorder. Psych Res20: 87-95
24.
Kent J M, Papp L A, Martinez J M, Browne S T, Coplan J D, Klein D F, Gorman J M. (2001) Specificity of panic response to CO2 inhalation in panic disorder: a comparison with major depression and premenstrual dysphoric disorder. Am J Psychiatry158: 58-67
25.
Klein D F (1993) False suffocation alarms, spontaneous panics and related conditions: an integrative hypothesis. Arch Gen Psychiatry50: 306-317
26.
Liotti M, Brannan S, Egan G, Shade R, Madden L, Abplanalp B, Robillard R, Lancaster J, Zamarripa F E, Fox P T, Denton D. (2001) Brain responses associated with consciousness of breathlessness (air hunger). PNAS98: 2035-2040
27.
Papp L A, Klein D F, Martinez J M, Schneier F, Cole R, Liebowitz M R, Hollander E, Fyer A J, Jordan F, Gorman J M. (1993) Diagnostic and substance specificity of carbon dioxide-induced panic. Am J Psychiatry150: 250-257
28.
Papp L A, Martinez J M, Klein D F, Coplan J D, Norman R G, Cole Ret al. (1997) Respiratory psychophysiology of panic disorder: three respiratory challenges in 98 subjects. Am J Psychiatry154: 1557-1565
29.
Perna G, Battaglia M, Garberi A, Arancio C, Bertani A, Bellodi L (1994) Carbon dioxide/Oxygen challenge test in panic disorder. Psych Res52: 159-171
30.
Perna G, Bertani A, Caldirola D, Gabriele A, Cocchi S, Bellodi L (2002) Antipanic drug modulation of 35% CO2 hyperreactivity and short-term treatment outcome. J Clin Psychopharmacol22: 300-308
31.
Perna G, Caldirola D, Namia C, Cucchi M, Vanni G, Bellodi L (2004a) Language of dyspnea in panic disorder. Depress Anxiety20: 32-38
32.
Perna G, Bertani A, Caldirola D, Di Pasquale D, Migliarese G, Bellodi L (2004b) Modulation of hyperreactivity to 35% CO2 after one week of treatment with paroxetine and reboxetine: a double-blind, randomized study. J Clin Psychopharmacol24: 277-282
33.
Pols H, Zanderbergen J, de Loof C, Griez E (1991) Attenuation of carbon dioxide-induced panic after clonazepam treatment. Acta Psychiatrica Scandinavica84: 585-586
34.
Pols H, Verburg K, Hauzer R, Meijer J, Griez E (1996) Alprazolam premedication and 35% carbon dioxide vulnerability in panic patients. Biol Psychiatry40: 913-917
35.
Rapee R M, Sanderson W C, McCauley P A, Di Nardo P (1992) Differences in reported symptom profile between panic disorder and other DSM-III-R anxiety disorders. Behaviour Research and Therapy30: 45-52
36.
Rassovsky Y, Kushner M G (2003) Carbon dioxide in the study of panic disorder: issues of definition, methodology and outcome. Anxiety Disorders17: 1-32
37.
Roth W T, Wilhelm F H, Trabert W (1998) Autonomic instability during relaxation in panic disorder. Psych Res80: 155-164
38.
Sanderson W C, Wetzler S, Asnis G M (1994) Alprazolam blockade of CO2-provoked panic in patients with panic disorder. Am J Psychiatry151: 1220-1222
39.
Schmidt N B, Forsyth J P, Santiago H T, Trakowski J H (2002) Classification of panic attack subtypes in patients and normal controls in response to biological challenge: implications for assessment and treatment. J Anxiety Disorders16: 625-638
40.
Schruers K, van Diest R, Overbeek T, Griez E (2002) Acute L-5-hydroxytryptophan administration inhibits carbon dioxide-induced panic in panic disorder patients. Psych Res113: 237-243
41.
Schruers K, Griez E (2004) The effects of tianeptine or paroxetine on 35% CO2 provoked panic in panic disorder. J Psychopharmacol18: 553-558
42.
Sheehan D V, Lecrubier Y (1994) Mini International Neuropsychiatric Interview (MINI). University of South Florida Institute for Research in Psychiatry, Tampa, Florida and INSERM - Hopital de la Salpétrière, Paris, France
43.
Spielberger C D (1983) Manual for the State-Trait Anxiety Inventory, rev edn.Consulting Psychologists Press, Palo Alto, CA
44.
van Beck N and Griez E (2000) Reactivity to a 35% CO2 challenge in healthy first-degree relatives of patients with panic disorder. Biol Psychiatry47: 830-835
45.
Verburg K, Pols H, de Leeuw M, Griez E (1998) Reliability of the 35% carbon dioxide panic provocation challenge. Psych Res78: 207-214
46.
Wilhelm F H, Trabert W, Roth W T (2001) Physiologic instability in panic disorder and generalized anxiety disorder. Biol Psychiatry49: 596-605
47.
Woods S W, Charney D S, Goodman W K, Heninger G R (1988) Carbon dioxide-induced anxiety. Arch Gen Psychiatry45: 43-52
48.
Woods S W, Krystal J H, Heninger G R, Charney D S (1989) Effects of alprazolam and clonidine on carbon dioxide-induced increases in anxiety ratings in healthy human subjects. Life Sciences45: 233-242
